Free Investing

Joseph Krueger submits: At the 28th annual JP Morgan Healthcare conference, which ran from January 11- January 14th 2010, there were more than 300 companies represented, making their presentations to more than 6000 public and private equity and venture capital investors.Leading up to the conference and early last week there was bullish movement in many companies presenting at the conference. Many of the many of the larger companies like Amgen (AMGN), Genzyme (GENZ), Biogen (BIIB), Celgene (CELG), Gilead Sciences (GILD), TEVA Pharmaceuticals TEVA), Watson Pharmaceuticals (WPI) and OSI Pharmaceuticals (OSIP) previewed 2009 earnings during the conference.Complete Story »

Ron Rowland submits:The number of funds on ETF Deathwatch jumped 13% to 128 this month from 113 in November. The count consists of 88 ETFs and 40 ETNs that failed to generate at least $100,000 in average daily value traded (ADVT) for the past month. E-TRACS CMCI Short Platinum Excess Return (PTD) headed the list for the fourth month in a row. PTD saw action on only one day in November and it was for only 100 shares. So far in 2009 PTD has only traded on 33 days. In the August-November period it traded on just 10 days for a cumulative volume of 1,100 shares while posting 74 days of zero volume. Its highest volume day during that four-month span was just 300 shares.Complete Story »